CHLOROTHIAZIDE SODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Chlorothiazide Sodium, and when can generic versions of Chlorothiazide Sodium launch?
Chlorothiazide Sodium is a drug marketed by Am Regent, Fresenius Kabi Usa, Rk Pharma, Sagent Pharms Inc, and Sun Pharm. and is included in five NDAs.
The generic ingredient in CHLOROTHIAZIDE SODIUM is chlorothiazide sodium. There are forty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the chlorothiazide sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Chlorothiazide Sodium
A generic version of CHLOROTHIAZIDE SODIUM was approved as chlorothiazide sodium by FRESENIUS KABI USA on October 16th, 2009.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHLOROTHIAZIDE SODIUM?
- What are the global sales for CHLOROTHIAZIDE SODIUM?
- What is Average Wholesale Price for CHLOROTHIAZIDE SODIUM?
Summary for CHLOROTHIAZIDE SODIUM
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 9 |
| Clinical Trials: | 4 |
| Patent Applications: | 14 |
| What excipients (inactive ingredients) are in CHLOROTHIAZIDE SODIUM? | CHLOROTHIAZIDE SODIUM excipients list |
| DailyMed Link: | CHLOROTHIAZIDE SODIUM at DailyMed |
Recent Clinical Trials for CHLOROTHIAZIDE SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Vanderbilt University | Phase 4 |
| National Heart, Lung, and Blood Institute (NHLBI) | Phase 1 |
| Yale University | Phase 1 |
Pharmacology for CHLOROTHIAZIDE SODIUM
| Drug Class | Thiazide Diuretic |
| Physiological Effect | Increased Diuresis |
Anatomical Therapeutic Chemical (ATC) Classes for CHLOROTHIAZIDE SODIUM
US Patents and Regulatory Information for CHLOROTHIAZIDE SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Am Regent | CHLOROTHIAZIDE SODIUM | chlorothiazide sodium | INJECTABLE;INJECTION | 202561-001 | Apr 22, 2013 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sagent Pharms Inc | CHLOROTHIAZIDE SODIUM | chlorothiazide sodium | INJECTABLE;INJECTION | 202462-001 | May 29, 2015 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fresenius Kabi Usa | CHLOROTHIAZIDE SODIUM | chlorothiazide sodium | INJECTABLE;INJECTION | 090896-001 | Oct 16, 2009 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Rk Pharma | CHLOROTHIAZIDE SODIUM | chlorothiazide sodium | INJECTABLE;INJECTION | 202493-001 | Jun 18, 2014 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
